| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.87B | 143.88B | 159.37B | 164.08B | 164.97B | 136.93B |
| Gross Profit | 28.32B | 26.11B | 28.35B | 26.83B | 25.47B | 24.19B |
| EBITDA | 20.79B | 18.08B | 20.98B | 19.78B | 19.10B | 18.42B |
| Net Income | 12.31B | 8.68B | 12.86B | 11.86B | 11.24B | 11.04B |
Balance Sheet | ||||||
| Total Assets | 210.30B | 254.57B | 216.57B | 211.20B | 194.78B | 173.00B |
| Cash, Cash Equivalents and Short-Term Investments | 22.54B | 44.49B | 16.83B | 24.99B | 25.14B | 23.46B |
| Total Debt | 33.50B | 59.08B | 34.50B | 28.50B | 21.44B | 9.42B |
| Total Liabilities | 81.42B | 116.50B | 87.48B | 83.17B | 77.13B | 62.20B |
| Stockholders Equity | 128.88B | 134.59B | 129.09B | 124.41B | 114.30B | 107.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 39.29B | -5.39B | -4.63B | -7.14B | 13.34B |
| Operating Cash Flow | 0.00 | 42.99B | -2.17B | -1.64B | -4.35B | 17.07B |
| Investing Cash Flow | 0.00 | -22.06B | -1.98B | -972.00M | -1.84B | -3.47B |
| Financing Cash Flow | 0.00 | 6.66B | -3.70B | 2.52B | 7.85B | -9.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ¥16.05B | 15.63 | ― | 1.39% | -1.70% | 409.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥122.69B | 9.39 | ― | 2.89% | 16.39% | 101.50% | |
62 Neutral | ¥148.55B | 11.44 | ― | 3.44% | 1.86% | 11.05% | |
61 Neutral | ¥37.61B | 7.80 | ― | 3.88% | 0.72% | 30.10% | |
60 Neutral | ¥110.27B | 12.80 | ― | 3.81% | -9.72% | -31.50% | |
59 Neutral | ¥100.84B | 11.00 | ― | 3.13% | 10.13% | 13.31% |